Oncolix Inc. (fka ONCX)

[reaper247]

Cutting through the ONCX clutter and nonsense.

Oncolix is a bio/pharma that is currently engaged in phase one FDA clinical trials for cancer treatment.

Oncolix has invested over ten years in R&D and raised over $15M in private investment from accredited investors (endowments, institutional investors and high net worth individuals,) before becoming a public company in 2017.

Early funding came from the Susan G. Komen foundation, the US government and the former CEO of GlaxoSmithKline (NYSE: GSK) Ernest Mario.

Preclinical assessments were provided by MD Anderson Treatment Centers.

Typically, a company that is participating in phase one FDA clinical trials, support market valuations of $100,000,000+.

This is something we should all consider.

Back when MJ bio/pharmas were raging, you would often see market values of $100M, $200 or even $300M.

So lets look at valuations.

If a bloated pig MJ bio/pharma has a market capitalization of $200,000,000 and an O/S of 5B shares, that PPS is .04. Its just math.

Even a fully diluted ONCX with an O/S of 1B and a share price of .04 would give Oncolix a market cap of just $40,000,000.

So….

With an O/S of 200M shares and a PPS of .03, ONCX has a public valuation of just $6,000,000.

A 1000% gain from the current PPS would give ONCX a market cap of only $60,000,000.

It should be twice that high, just to get to a conservative market valuation of $120,000,000.

With an O/S of 200.000.000, ONCX should be trading @ at least .60 PPS.

I understand that there are people who are lurking. I know their enthusiasm and opinions aren’t being heard.

Maybe they don’t want to be harassed or ridiculed for their opinions.

ONCX has tremendous potential, even with the notes.

IMO and FWIW.